Ensuring Quality and Reducing Risk
Simbec-Orion is part of the MHRA Phase I Accreditation Scheme, and has carried out over 2000 clinical pharmacology trials, with all drug types, over more than 45 years. Our extensive experience with the MHRA, EMA and FDA will add valuable insight to your clinical development plans.
We have significant experience in First-in-Human trials with a strong focus on participant safety, risk management and adding maximum value to your protocol through adaptive trial design.
Our pharmacology and medical teams will use their knowledge and expertise to advise on enhancements to your protocol development and study design approach. Our specialist advice will ensure quality is built in from the outset to enable efficient delivery of your early phase results.